China Greenlights First Stem Cell Therapy On Mixed Clinical Findings

Supportive Regulatory Environment

 
• By Dexter Jie Yan
  
Mesenchymal cell
The hUC-MSC PLEB001 is a human umbilical cord-derived mesenchymal stem cell (MSC) therapy. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Approvals

More from Cell & Gene Therapies